Pfizer ROA 2006-2018 | PFE

Current and historical return on assets (ROA) values for Pfizer (PFE) over the last 10 years.
Pfizer Annual ROA - Return on Assets
2017 12.43
2016 4.21
2015 4.17
2014 5.44
2013 6.63
2012 4.86
2011 4.18
2010 4.27
2009 4.01
2008 7.24
2007 7.16
2006 9.54
2005 6.51
Pfizer Quarterly ROA - Return on Assets
Q2 2018 2.35
Q1 2018 2.17
Q4 2017 7.15
Q3 2017 1.66
Q2 2017 1.83
Q1 2017 1.85
Q4 2016 0.45
Q3 2016 0.76
Q2 2016 1.21
Q1 2016 1.87
Q4 2015 -0.10
Q3 2015 1.25
Q2 2015 1.64
Q1 2015 1.48
Q4 2014 0.75
Q3 2014 1.56
Q2 2014 1.69
Q1 2014 1.32
Q4 2013 1.53
Q3 2013 1.48
Q2 2013 1.99
Q1 2013 1.40
Q4 2012 0.70
Q3 2012 1.64
Q2 2012 1.64
Q1 2012 0.93
Q4 2011 0.42
Q3 2011 1.19
Q2 2011 1.29
Q1 2011 1.14
Q4 2010 1.54
Q3 2010 0.45
Q2 2010 1.28
Q1 2010 1.03
Q4 2009 0.31
Q3 2009 2.04
Q2 2009 1.62
Q1 2009 2.22
Q4 2008 0.21
Q3 2008 1.96
Q2 2008 2.37
Q1 2008 2.36
Q4 2007 2.39
Q3 2007 0.73
Q2 2007 1.22
Q1 2007 3.04
Q4 2006 1.29
Q3 2006 2.98
Q2 2006 2.05
Q1 2006 3.55
Q4 2005 2.12
Q3 2005 1.34
Q2 2005 3.01
Q1 2005 0.22
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $243.651B $52.546B
Pfizer Inc. is a research-based, global pharmaceutical company that discovers, develops, manufactures, and markets medicines for humans and animals. The Company's diversified global healthcare portfolio includes human and animal biologic and small molecule medicines and vaccines, as well as nutritional products and consumer healthcare products. Pfizer's Animal Health business unit discovers, develops and sells products for the prevention and treatment of diseases in livestock and companion animals. It sells its products to wholesalers, distributors, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, veterinarians, livestock producers, and grocery and convenience stores. Pfizer Inc. is headquartered in New York.
Stock Name Country Market Cap PE Ratio
Johnson & Johnson (JNJ) United States $350.789B 16.76
Novartis AG (NVS) Switzerland $190.263B 16.32
Merck (MRK) United States $178.137B 15.73
AbbVie (ABBV) United States $145.067B 14.17
Novo Nordisk (NVO) Denmark $114.528B 18.31
Eli Lilly (LLY) United States $109.815B 20.33
Sanofi (SNY) France $104.261B 13.20
AstraZeneca (AZN) United Kingdom $99.745B 10.97
GlaxoSmithKline (GSK) United Kingdom $99.569B 13.30
Bristol-Myers Squibb (BMY) United States $96.944B 17.55